Advanced search
Publication Cover
Renal Failure Volume 43, 2021 - Issue 1
Submit an article Journal homepage
1,363
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Urinary liver-type fatty acid-binding protein variation as a predictive value of short-term mortality in intensive care unit patients

Ginga SuzukiCritical Care Center, Toho University Omori Medical Center, Tokyo, JapanCorrespondence[email protected]
,
Ryo IchibayashiCritical Care Center, Toho University Omori Medical Center, Tokyo, Japan
,
Saki YamamotoCritical Care Center, Toho University Omori Medical Center, Tokyo, Japan
,
Hibiki SerizawaCritical Care Center, Toho University Omori Medical Center, Tokyo, Japan
,
Yoshimi NakamichiCritical Care Center, Toho University Omori Medical Center, Tokyo, Japan
,
Masayuki WatanabeCritical Care Center, Toho University Omori Medical Center, Tokyo, Japan
&
Mitsuru HondaCritical Care Center, Toho University Omori Medical Center, Tokyo, Japan
 show all
Pages 1041-1048 | Received 22 Feb 2021, Accepted 10 Jun 2021, Published online: 30 Jun 2021

References

  • Xu Y, Xie Y, Shao X, et al. L-FABP: a novel biomarker of kidney disease. Clin Chim Acta. 2015;445:85–90.
  • Suzuki G, Ichibayashi R, Yamamoto S, et al. Clinical significance of urinary L-FABP in the emergency department. Int J Emerg Med. 2019;12(1):24.
  • Coca SG, Yalavarthy R, Concato J, et al. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int. 2008;73(9):1008–1016.
  • McMahon BA, Galligan M, Redahan L, et al. Biomarker predictors of adverse acute kidney injury outcomes in critically ill patients: the Dublin Acute Biomarker Group Evaluation Study. Am J Nephrol. 2019;50(1):19–28.
  • Doi K, Negishi K, Ishizu T, et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med. 2011;39:2464–2469.
  • Pelsers MM, Namiot Z, Kisielewski W, et al. Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem. 2003;36(7):529–535.
  • Guthmann F, Börchers T, Wolfrum C, et al. Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates. Mol Cell Biochem. 2002;239(1–2):227–234.
  • Thuijls G, van Wijck K, Grootjans J, et al. Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg. 2011;253(2):303–308.
  • Machado MC, Barbeiro HV, Pinheiro da Silva F, et al. Circulating fatty acid binding protein as a marker of intestinal failure in septic patients. Crit Care. 2012;16(6):455.
  • Bingold TM, Franck K, Holzer K, et al. Intestinal fatty acid binding protein: a sensitive marker in abdominal surgery and abdominal infection. Surg Infect. 2015;16(3):247–253.
  • Kokesova A, Coufal S, Frybova B, et al. The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis. PLOS One. 2019;14(1):e0210797.
  • Cheng S, Yu J, Zhou M, et al. Serologic intestinal-fatty acid binding protein in necrotizing enterocolitis diagnosis: a meta-analysis. Biomed Res Int. 2015;2015:156704.
  • Coufal S, Kokesova A, Tlaskalova-Hogenova H, et al. Urinary I-FABP, L-FABP, TFF-3, and SAA can diagnose and predict the disease course in necrotizing enterocolitis at the early stage of disease. J Immunol Res. 2020;2020:3074313.
  • Voth M, Holzberger S, Auner B, et al. I-FABP and L-FABP are early markers for abdominal injury with limited prognostic value for secondary organ failures in the post-traumatic course. Clin Chem Lab Med. 2015;53(5):771–780.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull. 1979;86(2):420–428.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174.
  • Goulenok C, Monchi M, Chiche JD, et al. Influence of overweight on ICU mortality: a prospective study. Chest. 2004;125(4):1441–1445.
  • Hoeboer SH, Oudemans-van Straaten HM, Groeneveld AB. Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever. BMC Pulm Med. 2015;15(1):22.
  • Basile-Filho A, Lago AF, Menegueti MG, et al. The use of Apache II, SOFA, SAPS 3, C-reactive protein/albumin ratio, and lactate to predict mortality of surgical critically ill patients: a retrospective cohort study. Medicine. 2019;98(26):e16204.
  • Coca SG, Garg AX, Thiessen-Philbrook H, TRIBE-AKI Consortium, et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol. 2014;25(5):1063–1071.
  • Parr SK, Clark AJ, Bian A, et al. Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. Kidney Int. 2015;87(3):640–648.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.